Interventions for improving clinical outcomes and health-related quality-of-life for people living with skeletal dysplasias: an evidence gap map
-
Published:2023-06-09
Issue:10
Volume:32
Page:2751-2762
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Moy Naomi, Flynn Darren, Henriquez Josefa, Connelly Luke B., Vale Luke, Paolucci FrancescoORCID
Abstract
Abstract
Purpose
Skeletal dysplasias are rare genetic disorders that are characterized by abnormal development of bone and cartilage. There are multiple medical and non-medical treatments for specific symptoms of skeletal dysplasias e.g. pain, as well as corrective surgical procedures to improve physical functioning. The aim of this paper was to develop an evidence-gap map of treatment options for skeletal dysplasias, and their impact on patient outcomes.
Methods
We conducted an evidence-gap map to identify the available evidence on the impact of treatment options on people with skeletal dysplasias on clinical outcomes (such as increase in height), and dimensions of health-related quality of life. A structured search strategy was applied to five databases. Two reviewers independently assessed articles for inclusion in two stages: titles and abstracts (stage 1), and full text of studies retained at stage 2.
Results
58 studies fulfilled our inclusion criteria. The included studies covered 12 types of skeletal dysplasia that are non-lethal with severe limb deformities that could result in significant pain and numerous orthopaedic interventions. Most studies reported on the effect of surgical interventions (n = 40, 69%), followed by the effect of treatments on dimensions of health quality-of-life (n = 4, 6.8%) and psychosocial functioning (n = 8, 13.8%).
Conclusion
Most studies reported on clinical outcomes from surgery for people living with Achondroplasia. Consequently, there are gaps in the literature on the full range of treatment options (including no active treatment), outcomes and the lived experience of people living with other skeletal dysplasias. More research is warranted to examine the impact of treatments on health-related quality-of-life of people living with skeletal dysplasias, including their relatives to enable them to make preference- and valued based decisions about treatment.
Funder
H2020 European Research Council Alma Mater Studiorum - Università di Bologna
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference83 articles.
1. Mortier, G. R., Cohn, D. H., Cormier-Daire, V., Hall, C., Krakow, D., Mundlos, S., Nishimura, G., Robertson, S., Sangiorgi, L., Savarirayan, R., Sillence, D., Superti-Furga, A., Unger, S., & Warman, M. L. (2019). Nosology and classification of genetic skeletal disorders: 2019 revision. American Journal of Medical Genetics Part A, 179(12), 2393–2419. https://doi.org/10.1002/ajmg.a.61366 2. Orioli, I., Castilla, E., & Barbosa-Neto, J. (1986). The birth prevalence rates for the skeletal dysplasias. Journal of Medical Genetics, 23(4), 328–332. 3. Lachman, R., Rimoin, D., & Spranger, J. (1988). Metaphyseal chondrodysplasia, Schmid type clinical and radiographic deliniation with a review of the literature. Pediatric Radiology, 18(2), 93–102. 4. Stevens, P. M., & Novais, E. N. (2012). Multilevel guided growth for hip and knee varus secondary to chondrodysplasia. Journal of Pediatric Orthopaedics, 32(6), 626–630. 5. Al Kaissi, A., Ghachem, M. B., Nabil, N. M., Kenis, V., Melchenko, E., Morenko, E., Grill, F., Ganger, R., & Kircher, S. G. (2018). Schmid’s type of metaphyseal chondrodysplasia: Diagnosis and management. Orthopaedic Surgery, 10(3), 241–246. https://doi.org/10.1111/os.12382
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|